Cargando…
Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
Autores principales: | Jiang, Hua, Song, Bo, Wang, Peng, Shi, Bizhi, Li, Qixiang, Fan, Mingliang, Di, Shengmeng, Yang, Jie, Li, Zonghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712292/ https://www.ncbi.nlm.nih.gov/pubmed/28929447 http://dx.doi.org/10.1007/s13238-017-0472-9 |
Ejemplares similares
-
Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
por: Di, Shengmeng, et al.
Publicado: (2019) -
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
por: Liu, Yifan, et al.
Publicado: (2023) -
Challenges of Anti-Mesothelin CAR-T-Cell Therapy
por: Zhai, Xuejia, et al.
Publicado: (2023) -
Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
por: Castelletti, Laura, et al.
Publicado: (2021) -
Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo
por: Ye, Lin, et al.
Publicado: (2019)